<?xml version="1.0" encoding="UTF-8"?>
 <rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:cc="http://web.resource.org/cc/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/">
  <channel rdf:about="http://pinboard.in">
    <title>Pinboard (Michael.Massing)</title>
    <link>https://pinboard.in/u:Michael.Massing/public/</link>
    <description>recent bookmarks from Michael.Massing</description>
    <items>
      <rdf:Seq>	<rdf:li rdf:resource="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/217393"/>
	<rdf:li rdf:resource="https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a3.htm"/>
	<rdf:li rdf:resource="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357617/"/>
	<rdf:li rdf:resource="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215499/"/>
	<rdf:li rdf:resource="https://link.springer.com/article/10.1007/s00125-012-2690-2"/>
	<rdf:li rdf:resource="https://care.diabetesjournals.org/content/43/1/117"/>
	<rdf:li rdf:resource="https://www.hcup-us.ahrq.gov/reports/statbriefs/sb243-Severe-Maternal-Morbidity-Delivery-Trends-Disparities.jsp"/>
	<rdf:li rdf:resource="https://www.jointcommission.org/assets/1/6/Speakup_Diabetes_brochure.pdf"/>
	<rdf:li rdf:resource="http://www.slate.com/articles/health_and_science/medical_examiner/2016/06/muhammad_ali_s_peaceful_death_surrounded_by_family_and_not_doctors_shows.html"/>
	<rdf:li rdf:resource="http://www.d-is-for-diabetes.com/pr/pr-18mar2016.htm"/>
	<rdf:li rdf:resource="http://care.diabetesjournals.org/content/early/2016/01/29/dc15-1264.abstract"/>
	<rdf:li rdf:resource="http://www.hsph.harvard.edu/news/magazine/secrets-of-sound-health/"/>
	<rdf:li rdf:resource="http://blogs.wsj.com/economics/2014/01/09/diabetics-may-be-getting-sick-because-they-cant-afford-food/"/>
	<rdf:li rdf:resource="http://www.nejm.org/doi/full/10.1056/NEJMe1306987"/>
	<rdf:li rdf:resource="http://www.diabetesincontrol.com/index.php?option=com_content&amp;task=view&amp;id=12007&amp;Itemid=8"/>
	<rdf:li rdf:resource="http://www.dlife.com/diabetes-news/content/welldoc%C2%AE-diabetesmanager%C2%AE-cuts-hospital-and-er-visits-half-0"/>
	<rdf:li rdf:resource="http://www.huffingtonpost.com/2011/11/23/energy-drink-hospitalizations_n_1110603.html?ir=Food"/>
	<rdf:li rdf:resource="http://www.diabetesselfmanagement.com/blog/Tara_Dairman/Drug_Combo_Linked_to_Increased_Health_Risks"/>
      </rdf:Seq>
    </items>
  </channel><item rdf:about="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/217393">
    <title>Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus: Clinical and Biochemical Differences | Acid Base, Electrolytes, Fluids | JAMA Internal Medicine | JAMA Network</title>
    <dc:date>2021-04-06T03:57:47+00:00</dc:date>
    <link>https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/217393</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Of 138 patients admitted for moderate-to-severe DKA, 30 had type 2 diabetes. A greater proportion of the type 2 diabetes group was Latino American or African American (P<.001). Thirty-five admissions (19.9%) were for newly diagnosed diabetes. A total of 85% of all admissions involved discontinuation of medication use, 69.2% in the type 2 group. Infections were present in 21.6% of the type 1 and 48.4% of the type 2 diabetes admissions. A total of 21% of patients with type 1 diabetes and 70% with type 2 diabetes had a body mass index greater than 27. Although the type 1 diabetes group was more acidotic (arterial pH, 7.21 ± 0.12 vs 7.27 ± 0.08; P<.001), type 2 diabetes patients required longer treatment periods (36.0 ± 11.6 vs 28.9 ± 8.9 hours, P = .01) to achieve ketone-free urine. Complications from therapy were uncommon.]]></description>
<dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D trends incidence prevalence peer-reviewed research hospitalization human retrospective cohort vulnerability susceptibility correlation in vivo situ 2 T2D emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:5fe627671df5/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trends"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:incidence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevalence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vulnerability"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:susceptibility"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a3.htm">
    <title>Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality — United States, 2000–2014 | MMWR</title>
    <dc:date>2021-04-06T03:40:18+00:00</dc:date>
    <link>https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a3.htm</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[iabetic ketoacidosis (DKA) is a life-threatening complication of diabetes, a disease that affects approximately 30 million persons in the United States. DKA is more common among persons with type 1 diabetes.

What is added by this report?

After a slight decline during 2000–2009, hospitalizations for DKA increased in the United States during 2009–2014 among all age groups and were highest among persons aged <45 years. Concurrently, in-hospital case-fatality rates among persons with DKA consistently decreased from 2000 to 2014.

What are the implications for public health practice?

DKA is a life-threatening but avoidable complication of diabetes. Prevention measures, such as diabetes self-management education, might help reverse the increasing trend in DKA, especially in persons aged <45 years who have the highest DKA rates.]]></description>
<dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D age trends incidence prevalence peer-reviewed research hospitalization human retrospective cohort vulnerability susceptibility correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:ad19c098ac31/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:age"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trends"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:incidence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevalence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vulnerability"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:susceptibility"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357617/">
    <title>Diabetic ketoacidosis at the onset of Type 1 diabetes in young children</title>
    <dc:date>2021-04-05T04:07:31+00:00</dc:date>
    <link>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357617/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D Italy children peer-reviewed research in vivo situ hospitalization human retrospective cohort insurance correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:26dac5c5ece7/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Italy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insurance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215499/">
    <title>Frequency of Ketoacidosis in Newly Diagnosed Type 1 Diabetic Children</title>
    <dc:date>2021-04-05T04:05:19+00:00</dc:date>
    <link>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215499/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D Iran children peer-reviewed research in vivo situ hospitalization human retrospective cohort insurance correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:64679032977c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Iran"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insurance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://link.springer.com/article/10.1007/s00125-012-2690-2">
    <title>Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review | SpringerLink</title>
    <dc:date>2021-04-05T04:04:07+00:00</dc:date>
    <link>https://link.springer.com/article/10.1007/s00125-012-2690-2</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D international comparison systematic review children peer-reviewed research in vivo situ hospitalization human retrospective cohort insurance correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:ba27906b807d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:international"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:comparison"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:systematic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:review"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insurance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://care.diabetesjournals.org/content/43/1/117">
    <title>Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Colorado Children, 2010–2017 | Diabetes Care</title>
    <dc:date>2021-04-05T04:02:19+00:00</dc:date>
    <link>https://care.diabetesjournals.org/content/43/1/117</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D Colorado children peer-reviewed research in vivo situ hospitalization human retrospective cohort nsurance correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:54ec3e0057dc/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Colorado"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:nsurance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.hcup-us.ahrq.gov/reports/statbriefs/sb243-Severe-Maternal-Morbidity-Delivery-Trends-Disparities.jsp">
    <title>Trends and Disparities in Delivery Hospitalizations Involving Severe Maternal Morbidity, 2006-2015 #243</title>
    <dc:date>2018-11-21T01:05:20+00:00</dc:date>
    <link>https://www.hcup-us.ahrq.gov/reports/statbriefs/sb243-Severe-Maternal-Morbidity-Delivery-Trends-Disparities.jsp</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>maternity mortality morbidity healthcare peer-reviewed research trend hospitalization</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:e7bdeba6f1f0/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:maternity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healthcare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trend"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.jointcommission.org/assets/1/6/Speakup_Diabetes_brochure.pdf">
    <title>[untitled]</title>
    <dc:date>2016-07-27T02:05:44+00:00</dc:date>
    <link>https://www.jointcommission.org/assets/1/6/Speakup_Diabetes_brochure.pdf</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @zsquaredmama: 
#DCDE]]></description>
<dc:subject>diabetes hospital hospitalization DCDE</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:bd29db5e1d2d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospital"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DCDE"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.slate.com/articles/health_and_science/medical_examiner/2016/06/muhammad_ali_s_peaceful_death_surrounded_by_family_and_not_doctors_shows.html">
    <title>Muhammad Ali’s peaceful death, surrounded by family and not doctors, shows his bravery in his final fight.</title>
    <dc:date>2016-06-07T16:20:08+00:00</dc:date>
    <link>http://www.slate.com/articles/health_and_science/medical_examiner/2016/06/muhammad_ali_s_peaceful_death_surrounded_by_family_and_not_doctors_shows.html</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Most patients over 75 years old with one of many serious underlying medical problems have less than a 10 percent chance of surviving CPR. For octogenarians living in nursing homes or other skilled care facilities with even moderate cognitive disabilities, those suffering from a stroke, metastatic cancer, major trauma, or septic shock (which Ali developed), the survival rate is less than 2 percent. By 85 years of age, such patients have less than a 1 percent chance of survival. The few that do survive often die on respirators after prolonged stays in intensive care units. Yet sadly, patients such as these frequently receive CPR, which, if the patient has any brain function, is about as painful a procedure as one can possibly imagine. It often saddens me that the last substance to enter a patient’s bloodstream is a heart stimulant rather than medication to ease pain and suffering.]]></description>
<dc:subject>death CPR risk benefit aging heroic measures intervention mortality dying Muhammad Ali earnest healthcare hospitalization institutionalization palliative care</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:25205aeb30fe/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:death"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:CPR"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:aging"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:heroic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:measures"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:intervention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dying"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Muhammad"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Ali"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:earnest"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healthcare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:institutionalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:palliative"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.d-is-for-diabetes.com/pr/pr-18mar2016.htm">
    <title>D-is-for-Diabetes: Medicare's Competitive Bidding Program Puts Beneficiaries' Lives at Risk</title>
    <dc:date>2016-05-17T15:08:31+00:00</dc:date>
    <link>http://www.d-is-for-diabetes.com/pr/pr-18mar2016.htm</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[The Forum built upon the GAO's analysis by examining access to diabetes testing supplies for Medicare beneficiaries living with diabetes and requiring insulin therapy.  Working with some of the nation's leading endocrinologists,* the Forum's study found that the Competitive Bidding Program disrupted beneficiaries' ability to access diabetes testing supplies, and this disruption was associated with an increase in mortality, higher hospitalization rates and inpatient costs.

"Self-monitoring blood glucose supplies are a critical component of diabetes care among insulin-treated individuals and the value of safe, effective testing supplies cannot be underestimated," said Jaime Davidson, M.D., clinical professor of Medicine at the University of Texas Southwestern Medical Center, and an author of the study. "We are particularly concerned about the disruption we detected in our analysis given the predominant use of rapid- and short-acting insulin by Medicare beneficiaries, who are at significantly greater risk for hypoglycemia than younger individuals with insulin-treated diabetes."

"We are troubled that CMS failed to detect these 'unintended' consequences and, instead, reported that the program was a success," said Gary A. Puckrein, Ph.D., president and CEO of the National Minority Quality Forum and a study author. "Based on our findings and employing the safety monitoring protocols commonly used to protect human subjects, we believe policymakers should immediately suspend the program until CMS can demonstrate its ability to effectively monitor the effects of the program, correct the structural flaws causing this problem and ensure that the lives of America's greatest generation are no longer at risk." 

The ahead of print article "Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis" can be found online: Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis . The full article will also be published here: http://dx.doi.org/10.2337/dc15-1264.]]></description>
<dc:subject>watchdog diabetes insulin-dependent SMBG supplies cost benefit mortality hospitalization competitive bidding Medicare in vivo situ human peer-reviewed research health disparities healthcare</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:633e1ae65331/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:watchdog"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin-dependent"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SMBG"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:supplies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cost"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:competitive"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:bidding"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Medicare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disparities"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healthcare"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://care.diabetesjournals.org/content/early/2016/01/29/dc15-1264.abstract">
    <title>Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis | Diabetes Care</title>
    <dc:date>2016-05-17T14:59:12+00:00</dc:date>
    <link>http://care.diabetesjournals.org/content/early/2016/01/29/dc15-1264.abstract</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RESEARCH DESIGN AND METHODS The study population consisted of insulin users: 43,939 beneficiaries in the nine test markets (TEST) and 485,688 beneficiaries in the nontest markets (NONTEST). TEST and NONTEST were subdivided: those with full self-monitoring of blood glucose (SMBG) supply acquisition (full SMBG) according to prescription and those with partial/no acquisition (partial/no SMBG). Propensity score–matched analysis was performed to reduce selection bias. Outcomes were impact of partial/no SMBG acquisition on mortality, inpatient admissions, and inpatient costs.

RESULTS Survival was negatively associated with partial/no SMBG acquisition in both cohorts (P < 0.0001). Coterminous with CBP (2010–2011), there was a 23.0% (P < 0.0001) increase in partial/no SMBG acquisition in TEST vs. 1.7% (P = 0.0002) in NONTEST. Propensity score–matched analysis showed beneficiary migration from full to partial/no SMBG acquisition in 2011 (1,163 TEST vs. 605 NONTEST) was associated with more deaths within the TEST cohort (102 vs. 60), with higher inpatient hospital admissions and associated costs.

CONCLUSIONS SMBG supply acquisition was disrupted in the TEST population, leading to increased migration to partial/no SMBG acquisition with associated increases in mortality, inpatient admissions, and costs. Based on our findings, more effective monitoring protocols are needed to protect beneficiary safety.

Received June 12, 2015.
Accepted January 9, 2016.
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis
Gary A. Puckrein, Gail Nunlee-Bland, Farhad Zangeneh, Jaime A. Davidson, Robert A. Vigersky, Liou Xu, Christopher G. Parkin, David G. Marrero
Diabetes Care 2016 Mar; http://dx.doi.org/10.2337/dc15-1264]]></description>
<dc:subject>diabetes insulin-dependent SMBG supplies cost benefit mortality hospitalization competitive bidding Medicare in vivo situ human peer-reviewed research</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:0e113542629d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin-dependent"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SMBG"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:supplies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cost"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:competitive"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:bidding"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Medicare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.hsph.harvard.edu/news/magazine/secrets-of-sound-health/">
    <title>Secrets of sound health | HSPH News | Harvard School of Public Health</title>
    <dc:date>2014-02-07T04:06:27+00:00</dc:date>
    <link>http://www.hsph.harvard.edu/news/magazine/secrets-of-sound-health/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Among children exposed to higher levels of jet roar before the airport was moved, stress hormones were higher and memory and reading comprehension lower. Their scores im­proved when the airport was moved—but the children newly exposed to the racket overhead began suffering the same deleterious effects.

“Calling noise a nuisance is like calling smog an inconve­nience. Noise must be considered a hazard to the health of people everywhere,” William Stewart, U.S. surgeon general in the late 1960s, prophetically remarked.

As Dominici and others have since shown, people who are bombarded daily by noise and seemingly inured to it may be suffering chronic biological stress of which they are completely unaware. And the damage may accrue over a lifetime. “It opens a whole series of questions about what exposure to noise does to your system,” says Dominici. “You may be adapting in your mind, but not in your body.”]]></description>
<dc:subject>noise environment health risk peer-reviewed research stress cardiovascular aging children urban design technological public pollution fight-or-flight hospitalization</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:d38adeb82dcf/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:noise"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:environment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:stress"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cardiovascular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:aging"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:urban"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:design"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:technological"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:public"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pollution"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fight-or-flight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://blogs.wsj.com/economics/2014/01/09/diabetics-may-be-getting-sick-because-they-cant-afford-food/">
    <title>Diabetics May Be Getting Sick Because They Can’t Afford Food - Real Time Economics - WSJ</title>
    <dc:date>2014-01-25T23:40:42+00:00</dc:date>
    <link>http://blogs.wsj.com/economics/2014/01/09/diabetics-may-be-getting-sick-because-they-cant-afford-food/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @diaTribeNews: Study in @Health_Affairs finds 27% increase in pwd hospitalization for hypo at end of month if low-income ?]]></description>
<dc:subject>diabetes self care food insecurity health disparities poverty etiology risk hunger economic economics cost social healthcare income correlation hospitalization hypoglycemia peer-reviewed research socioeconomic factor public epidemiology diet cause SDH determinants of T2D type 2 geography environment SDoH malnutrition</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:4d0b41cda335/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:food"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insecurity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disparities"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:poverty"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hunger"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:economic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:economics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cost"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:social"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healthcare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:income"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hypoglycemia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:socioeconomic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:public"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:epidemiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cause"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SDH"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:determinants"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:of"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:geography"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:environment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SDoH"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:malnutrition"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.nejm.org/doi/full/10.1056/NEJMe1306987">
    <title>Do Lifestyle Changes Reduce Serious Outcomes in Diabetes? — NEJM</title>
    <dc:date>2013-06-29T05:35:21+00:00</dc:date>
    <link>http://www.nejm.org/doi/full/10.1056/NEJMe1306987</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[The participants who received intensive lifestyle modifications experienced other benefits when compared to the diabetes education and support group, including decreased depressive symptoms, less self-reported retinopathy, and decreased risk of kidney disease.  Compared to the diabetes support and education group, the intensive lifestyle intervention reduced the average number of hospitalizations per year and the average number of medications per year. Hospitalizations were reduced by 11.9% from 0.193 to 0.17 hospitalizations per year, which translated into savings of $294 per year and $2,600 discounted over 10 years.  Moreover, the number of medications was reduced by 6.3% from 4.9 to 4.6 medications per year, translating into a savings of $278 per year and $2,487 discounted over 10 years. Average costs per year were $8,807 for the control group vs. $8,205 for the intervention group, leading to a significant reduction of $602 per year and $5,378 discounted over 10 years.  Significant reductions in hospitalizations occurred mainly among CV and pulmonary hospitalization, and significant reductions in medications occurred mainly among diabetes, lipid-lowering and antihypertensive medications.  The study ultimately shows that obese or overweight people with type 2 diabetes should increase the amount that they exercise and increase their weight loss.]]></description>
<dc:subject>peer-reviewed research cardiovascular risk diabetes obesity human in vivo physical activity type 2 T2D correlation support treatment self care education depression comorbidities intensive lifestyle intervention retinopathy kidney disease hospitalization morbidity healthcare cost economics harm reduction behavioral change management behavior tight control exercise body fat clinical trial stress distress factor therapy etiology mitigation prevention symptoms late-stage complications benefit situ cause</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:61128166265a/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cardiovascular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:obesity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:physical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:activity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:support"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:treatment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:depression"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:comorbidities"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:intensive"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:lifestyle"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:intervention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retinopathy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:kidney"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disease"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healthcare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cost"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:economics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:harm"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:reduction"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:change"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavior"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:control"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:exercise"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:body"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:stress"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:distress"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:therapy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mitigation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:symptoms"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:late-stage"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:complications"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cause"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.diabetesincontrol.com/index.php?option=com_content&amp;task=view&amp;id=12007&amp;Itemid=8">
    <title>Animas Corp [Johnson &amp; Johnson] Receives Warning Letter from the FDA</title>
    <dc:date>2012-02-12T22:11:50+00:00</dc:date>
    <link>http://www.diabetesincontrol.com/index.php?option=com_content&amp;task=view&amp;id=12007&amp;Itemid=8</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who were using its OneTouch Ping and 2020 pumps. The FDA ordered the Animas Corp. unit of J&J to explain why it kept selling pumps known to fail and also to submit a plan to rectify a failure to promptly report cases in which its device might have caused or contributed to death or serious injury....
In the issue with the Animas insulin pumps, some pump keypads for controlling how much insulin is injected were deteriorating prematurely, leading to failures. "We decided to go with a new keypad because it's more durable," [spokesperson Caoline] Pavis said.
But while Animas was lining up the new keypad supplier, it was still selling the older ones. The FDA demanded documents about the company's decision to do that.]]></description>
<dc:subject>corporatism capitalism mortality regulation medical devices insulin Johnson&amp;Johnson risk safety diabetes drug effects morbidity injury hospitalization ketoacidosis government accountability</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:e425bd3ef1c0/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corporatism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:capitalism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:devices"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Johnson&amp;Johnson"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:safety"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:drug"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:effects"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:injury"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:government"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:accountability"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.dlife.com/diabetes-news/content/welldoc%C2%AE-diabetesmanager%C2%AE-cuts-hospital-and-er-visits-half-0">
    <title>The WellDoc® DiabetesManager® Cuts Hospital and ER Visits in Half</title>
    <dc:date>2012-01-07T07:25:04+00:00</dc:date>
    <link>http://www.dlife.com/diabetes-news/content/welldoc%C2%AE-diabetesmanager%C2%AE-cuts-hospital-and-er-visits-half-0</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[[Medicaid patients using mobile-phone-based healthware] for an average of 12 months reduced their ER visits and hospital stays by 58% compared to the 12 months prior to the program....[Diabetes Manager provides real-time coaching for patients and clinical decision support to their healthcare providers, extending care beyond traditional office visits. One year results of the first randomized controlled trial (RCT) of a mobile phone-based diabetes coaching and decision support intervention met the trial's primary endpoint of reducing blood glucose levels over a usual-care control group (Diabetes Care, 2011-09)]. Patients using the DiabetesManager had an average decline in A1C of 1.9 percentage points compared to a 0.7-percentage-point decline seen among [controls]. Results were similar regardless of baseline A1C.... WellDoc® [builds technology to help manage chronic disease by providing patients and their healthcare providers with real-time, actionable information they can use to increase engagement and adherence].]]></description>
<dc:subject>medical research diabetes management healthware self care poverty Medicaid class health delivery technology peer-reviewed support blood glucose monitoring social outcome human in vivo situ clinical SMBG self-monitored trial phone low-tech morbidity treatment benefit cost hospitalization phone-based healthcare risk mortality correlation obstruction obstructionism expansion public disparities chronic disease burden determinants epidemiology data access T2D type 2 SDH of</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:877fc7eb3c25/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healthware"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:poverty"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Medicaid"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:class"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:delivery"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:technology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:support"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:monitoring"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:social"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:outcome"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SMBG"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self-monitored"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:phone"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:low-tech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:treatment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cost"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:phone-based"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healthcare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:obstruction"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:obstructionism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:expansion"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:public"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disparities"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:chronic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disease"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:burden"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:determinants"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:epidemiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:data"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:access"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SDH"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:of"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.huffingtonpost.com/2011/11/23/energy-drink-hospitalizations_n_1110603.html?ir=Food">
    <title>Energy Drink Hospitalizations Increase Tenfold In 4 Years</title>
    <dc:date>2011-11-24T22:51:31+00:00</dc:date>
    <link>http://www.huffingtonpost.com/2011/11/23/energy-drink-hospitalizations_n_1110603.html?ir=Food</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Though the study did not include alcoholic energy drinks[, 44% of hospitalizations] were related to using alcohol or other drugs with] energy drinks....

[T]he majority of cases did not involve alcohol, meaning the energy drinks can be dangerous by themselves.

Cecile Marczinski [of Northern Kentucky University] told WebMD that there may actually be more caffeine in energy drinks than is being reported.

'Marczinski said she recently learned that manufacturers don't have to report the total caffeine that's in the drinks. They only have to list what they add. There may be much more caffeine that comes from stimulant herbs like guarana.

'"The caffeine in these drinks could be vastly underestimated," she tells WebMD.'

In addition to the potentially dangerous combination with alcohol, researchers noted a number of reasons for energy drink related hospitalization, including arrhythmias, hypertension, dehydration and other serious medical conditions.]]></description>
<dc:subject>energy drinks risk medical research hospitalization caffeine peer-reviewed</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:9a9345479117/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:energy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:drinks"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:caffeine"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.diabetesselfmanagement.com/blog/Tara_Dairman/Drug_Combo_Linked_to_Increased_Health_Risks">
    <title>Drug Combo Linked to Increased Health Risks :: Diabetes Self-Management</title>
    <dc:date>2008-08-17T22:31:39+00:00</dc:date>
    <link>http://www.diabetesselfmanagement.com/blog/Tara_Dairman/Drug_Combo_Linked_to_Increased_Health_Risks</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA['A combination of two common types of Type 2 diabetes drugs may be linked to an increased risk of dying or ending up in the hospital due to cardiovascular disease...[but these results showed only] when risk of death was combined with risk of hospitalization....Trying to explain their findings, the researchers offered [that]:
* People who need combination therapy to control their blood glucose levels are likely to have more rapidly-progressing diabetes or have had diabetes for a longer period of time (or both); it may be the more advanced diabetes, rather than the treatment, that raises risks.
* Weight gain...associated with sulfonylureas [may increase risk] even when the drug is [combined] with metformin, which is not associated with weight gain.
* Sulfonylureas can cause hypoglycemia, and [combining them] with metformin may make hypoglycemic episodes harder to recover from because metformin prevents the liver from making extra glucose[, increasing] cardiovascular risk.'
]]></description>
<dc:subject>risk drug effects adverse morbidity hospitalization interaction peer-reviewed research metformin T2D diabetes treatment human in vivo mortality type 2 liver fatty body fat metabolic syndrome disorder etiology correlation clinical trial factor cause</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:228a2fa8fc62/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:drug"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:effects"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:adverse"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:interaction"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:metformin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:treatment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:liver"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fatty"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:body"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:metabolic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:syndrome"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disorder"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cause"/>
</rdf:Bag></taxo:topics>
</item>
</rdf:RDF>